Skip to content
healthcare.dev

QUZYTTIR

NDC 68118-200, Cetirizine Hydrochloride, injection, from ESTEVE PHARMACEUTICALS, S.A..

Product NDC
68118-200
Status
Listed
Labeler
ESTEVE PHARMACEUTICALS, S.A.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211415
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68118-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/mL

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
68118-200-10681180200101 VIAL, GLASS in 1 CARTON (68118-200-10) / 1 mL in 1 VIAL, GLASS (68118-200-01)
68118-200-256811802002525 VIAL, GLASS in 1 CARTON (68118-200-25) / 1 mL in 1 VIAL, GLASS (68118-200-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/573770f6-b76e-f6ba-e063-6294a90aa54d

Use it

Look up 68118-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68118-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68118-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.